EB1089, a Vitamin D Receptor Agonist, Reduces Proliferation and Decreases Tumor Growth Rate in a Mouse Model of Hormone-Induced Mammary Cancer

Cancer Letters - Ireland
doi 10.1016/j.canlet.2005.06.044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Stretching Reduces Tumor Growth in a Mouse Breast Cancer Model

Scientific Reports
Multidisciplinary
2018English

A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2018English

Hepatic Vitamin a Preloading Reduces Colorectal Cancer Metastatic Multiplicity in a Mouse Xenograft Model

Nutrition and Cancer
MedicineNutritionOncologyCancer ResearchDietetics
2012English

Vitamin E Reduces Chromosomal Damage and Inhibits Hepatic Tumor Formation in a Transgenic Mouse Model

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Chronologic Aging Decreases Tumor Angiogenesis and Metastasis in a Mouse Model of Head and Neck Cancer

International Journal of Oncology
Cancer ResearchOncology
2010English

A Combined Opiate Agonist and Antagonist Treatment Reduces Prolactin Secreting Pituitary Tumor Growth

Journal of Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2017English

Activating Transcription Factor-5 Knockdown Reduces Aggressiveness of Mammary Tumor Cells and Attenuates Mammary Tumor Growth

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2017English

Ron Receptor Signaling Augments Mammary Tumor Formation and Metastasis in a Murine Model of Breast Cancer

Cancer Research
Cancer ResearchOncology
2005English

Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis

Clinical Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy